The surgical robotics developer received $78.3m in funding from investors including New World Development, Lilly Asia Ventures and Meituan's DragonBall Capital fund.

China-based medical robotics developer Cornerstone Robotics has closed a RMB500m ($78.3m) series B round featuring pharmaceutical firm Eli Lilly, property developer New World Development and local services portal Meituan, DealStreetAsia reported yesterday.

Private equity firm Tsing Song Capital and venture capital firms Gaorong Capital, Qiming Venture Partners and K2VC filled out the participants in the round. Eli Lilly and Meituan invested through their Lilly Asia Ventures and DragonBall Capital vehicles respectively.

Founded in 2019, Cornerstone produces robots designed to carry…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Fernando Moncada Rivera

Fernando Moncada Rivera is a reporter at Global Corporate Venturing and also host of the CVC Unplugged podcast.
Email LinkedIn